In the context of vaccines manufactured to prevent COVID-19 pandemic, consider the following statements : 1. The Serum Institute of India produced COVID-19 vaccine named Covishield using mRNA platform. 2. Sputnik V vaccine is manufactured using vector based platform. 3. COVAXIN is an inactivated pathogen based vaccine. Which of the statements given above are correct?
2 and 3 Only
The question asks us to evaluate three statements about the manufacturing platforms used for specific COVID-19 vaccines: Covishield, Sputnik V, and COVAXIN.
Let's examine each statement carefully to determine its accuracy regarding the COVID-19 vaccine platforms.
This statement is incorrect. Covishield, which is the Indian manufactured version of the Oxford-AstraZeneca COVID-19 vaccine, is based on a viral vector platform, not an mRNA platform. Viral vector vaccines use a modified version of a different virus (the vector) to deliver instructions to cells to make a harmless piece of the virus that causes COVID-19.
This statement is correct. The Sputnik V vaccine, developed by Russia's Gamaleya Research Institute, is indeed a viral vector vaccine. It uses two different adenoviruses as vectors for the two doses.
This statement is correct. COVAXIN, developed by Bharat Biotech in India, is an inactivated whole virus vaccine. This means it uses an entire SARS-CoV-2 virus that has been killed or inactivated, so it cannot cause disease but can still trigger an immune response.
Based on our analysis:
Therefore, only statements 2 and 3 are correct regarding the platforms used for these COVID-19 vaccines.
We are looking for the option that includes only the correct statements. Our analysis showed that statements 2 and 3 are correct.
Let's look at the options:
The option that states "2 and 3 Only" correctly identifies the accurate statements about the COVID-19 vaccine platforms.
| Vaccine Name | Key Developer/Manufacturer | Vaccine Platform Type |
|---|---|---|
| Covishield (Oxford-AstraZeneca) | Serum Institute of India, AstraZeneca, University of Oxford | Viral Vector Vaccine |
| Sputnik V | Gamaleya Research Institute | Viral Vector Vaccine (uses two different adenoviruses) |
| COVAXIN | Bharat Biotech | Inactivated Whole Virus Vaccine |
| Comirnaty (Pfizer-BioNTech) | Pfizer, BioNTech | mRNA Vaccine |
| Spikevax (Moderna) | Moderna | mRNA Vaccine |
| Ad26.COV2.S (Johnson & Johnson/Janssen) | Johnson & Johnson/Janssen | Viral Vector Vaccine |
Vaccines work by teaching your immune system how to recognize and fight off a specific pathogen like a virus. Different technologies are used to create vaccines:
These vaccines deliver a piece of messenger RNA (mRNA) that contains instructions for making a specific protein found on the virus (like the spike protein of SARS-CoV-2). Your cells use these instructions to make the protein, and your immune system recognizes this protein as foreign and learns how to react if it encounters the actual virus.
These vaccines use a modified, harmless virus (the vector) to deliver genetic material from the target pathogen into cells. This genetic material tells the cells to make a protein from the pathogen, triggering an immune response without causing illness.
These vaccines are made by growing the pathogen (like a virus) and then killing or inactivating it using heat, chemicals, or radiation. The killed pathogen cannot cause disease, but its components can still be recognized by the immune system, leading to an immune response.
Understanding these different platforms helps clarify how various COVID-19 vaccines were designed and manufactured.